drugset / Trial / NCT02984228

Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis

NCT02984228

Phase 4 Completed 70 enrolled Hospital for Special Surgery, New York
RandomizedParallel-groupTriple-blindTreatment

Summary

This study seeks to expand the current literature in demonstrating potentially efficacious, conservative treatments in the management of glenohumeral osteoarthritis (OA) and will compare ultrasound-guided injections of hyaluronic acid vs. platelet-rich plasma. We aim to obtain information measuring potential benefits of these interventions and to observe for any adverse events.

Timeline

Start
2014-12
Primary completion
2020-11
Completion
2020-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hyaluronic Acid Other / unclassified Other
Comparator Platelet Rich Plasma Other / unclassified Other

Indications